GlaxoSmithKline Pharmaceuticals Overview

  • Status
  • Public

  • Employees
  • 3,840

  • Stock Symbol
  • 500660

Stock Symbol
  • Investments
  • 2

  • Share Price
  • $18.11

  • (As of Friday Closing)

GlaxoSmithKline Pharmaceuticals General Information


GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • Mumbai
  • India

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.11 $18.27 $17.35 - $25.32 $3.09B 169M 4.42K $1.33

GlaxoSmithKline Pharmaceuticals Financials Summary

In Thousands,
TTM 30-Jun-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 2,839,897 3,552,534 3,234,216 2,665,745
Revenue 448,619 439,959 393,226 453,815
EBITDA 106,741 104,350 57,198 44,750
Net Income 224,663 227,456 48,138 13,118
Total Assets 611,022 424,074 415,744
Total Debt 0 2,648 4,715 5,548
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Pharmaceuticals Board Members (7)

Name Representing Role Since
00000 000 GlaxoSmithKline Pharmaceuticals Board Member 000 0000
00000 000000000 Self Board Member 000 0000
000000 0000000000 Self Board Member 000 0000
You’re viewing 3 of 7 board members. Get the full list »

GlaxoSmithKline Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlaxoSmithKline Pharmaceuticals Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 16-Jul-2015 00000 0000 00000 Drug Discovery
Silarus Therapeutics 22-Sep-2014 Early Stage VC 0000 Drug Discovery
To view GlaxoSmithKline Pharmaceuticals’s complete investments history, request access »

GlaxoSmithKline Pharmaceuticals Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 16-Jul-2015 00000 00000 00 00000 Completed
  • 11 buyers
To view GlaxoSmithKline Pharmaceuticals’s complete exits history, request access »